Prednisolone vs. Ciclosporine in Severe Atopic Eczema

NCT00445081 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2010-10-29

No results posted yet for this study

Summary

To investigate the comparative efficacy of Ciclosporine A and Prednisolone in adult patients with severe atopic dermatitis.

Conditions

Interventions

DRUG

Prednisolone

DRUG

Ciclosporine A

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Jochen M Schmitt, MD MPH · Dpt. of Dermatology, TU Dresden, Fetscherstr 74, D-01307 Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-09-30
Completion
2010-01-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00445081 on ClinicalTrials.gov